To Top
0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z


The information contained in the Organizational Database (ODB) is provided for informational purposes only. There is no implied endorsement by NORD. NORD does not promote or endorse participation in any specific organization. The information is subject to change without notice. Every effort is made to ensure that the details for each entry are as current as possible.

Adenoid Cystic Carcinoma Organization International


P.O. Box 936
Lake Forest, CA 92630 USA

800 Number


Email Address

[email protected]


The Adenoid Cystic Carcinoma Organization International (ACCOI) provides education about adenoid cystic carcinoma, information on treatment and treatment facilities, current research updates. It helps to fund ACC research and provides an online support group for ACC patients and caregivers. Adenoid cystic carcinoma is a relatively rare form of cancer that most commonly develops in the salivary glands or other regions of the head and neck, but can occur in other parts of the body as well. Services of this non-profit organization include patient networking, support groups, and patient/physician education.

Please Note

The National Organization for Rare Disorders (NORD) web site, its databases, and the contents thereof are copyrighted by NORD. No part of the NORD web site, databases, or the contents may be copied in any way, including but not limited to the following: electronically downloading, storing in a retrieval system, or redistributing for any commercial purposes without the express written permission of NORD. Permission is hereby granted to print one hard copy of the information on an individual disease for your personal use, provided that such content is in no way modified, and the credit for the source (NORD) and NORD’s copyright notice are included on the printed copy. Any other electronic reproduction or other printed versions is strictly prohibited.

NORD's Rare Disease Information Database is copyrighted and may not be published without the written consent of NORD.